Implantable cytokine factories designed to deliver immunotherapy directly at the site of disease have taken an important step toward clinical reality. Researchers at Rice University, in collaboration ...

A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells that dramatically prolongs their effectiveness after being infused into ...

Autoimmune diseases result from a complex interaction of immune system imbalances, marked by a breakdown in self-tolerance and sustained inflammation. At the core of this dysregulation are ...

Autoimmune diseases stem from a complicated interplay of immune dysregulation, characterized by chronic inflammation and the loss of self-tolerance. Cytokines are central to these processes. These ...

In a new Science Advances paper, a research team led by scientists at Albert Einstein College of Medicine describe a manufacturing strategy for engineering immune cells that dramatically prolongs ...

For 25 years, researchers have engineered immune cells to hunt down HIV. The approach, known as chimeric antigen receptor (CAR) T-cell therapy, extracts a patient’s T cells, engineers them to ...

Slices of living human brain, taken during neurosurgery and kept alive in the lab, released far less of the inflammatory ...